Adaptive Mean Value Function Based Quality Assessment of Software Reliable Growth Models

Software growth models aims for reliability of the application over a period of time. Assessment of such models is of great interest since many faults arises with the models during the operation over a span of time. In this paper a adaptive mean value function based testing and estimation of the parameters were discussed. The proposed approach is also compared against the conventional testing approaches and found that the proposed method able to detect the fault under different scenario and proves to give better performance under a constrained environment. Keywords: Software reliability, Growth models, testing analysis, Fault detection and correction

Quality Assessment of Software Reliability Growth Models

The two main important properties of software components are reliability and robustness. Reliability can be defined as the probability of failure free operation and on the other hand the robustness can be defined as how far the software can be able to with stand for intrusion attacks. In both the cases there should be some metric to evaluate the performance of these properties. In this paper metrics are been described which can be used to assess the quality of performance for these properties within a software reliability growth model. Keywords: Software growth model, reliability, robustness, Quality metrics

A case of partial androgen insensitivity syndrome with undescended testis and clitoromegaly

Androgen insensitivity syndrome is a rare disorder of sex development that results from genetic mutations affecting the androgen receptor. Recently, we encountered a case of a 13-year-old individual who had been raised as female and sought medical attention for primary amenorrhea, which led to the discovery of partial androgen insensitivity syndrome. Early detection and gonad removal are necessary to mitigate the risk of cancer. Additional management steps such as corrective surgery and psychological support can also be valuable

Rate-dependence of the compressive and tensile strength of granites

The strength and rupture of geomaterials are integral to subsurface engineering practices, such as those required to optimise geothermal energy extraction. Of particular importance is the time- and strain-rate-dependence of material strength, which dictates the energy released upon failure, and impacts the magnitude of induced seismicity, fracture architecture and thus hydraulic conductivity and system permeability. Here, we performed a series of uniaxial compression and Brazilian tensile strength measurements at a range of deformation rates in order to constrain the impact of strain rate on the strength of G603 granite. The dense, low permeability, medium-grained granites were mechanically tested at 4 strain rates (or diametric equivalent strain rates in the case of Brazilian tests) from 10−5 to 10−2 s−1, such that sample failure was achieved in anything from below 1s at the fastest rate in tension, to over 1000s at the slowest rate in compression. The applied rates encompassed those recommended by ISRM and ASTM material testing standards for compressive and Brazilian tensile testing. We found a significant rate strengthening effect, whereby compressive and tensile strength both increased by approximately 35 % across the 4 orders of magnitude of strain rate tested. We found that the static Young's modulus remained relatively constant across this range of deformation rates, however variability was reduced at faster rates, owing to the reduced time for equilibration of the system to imposed stresses. The lower strength at slower strain rates causes smaller stress drops, indicating that rocks driven to compressive and tensile failure at slower rates release less energy upon failure. Such constraints of the strain-rate-dependence of material strength, in contrast to the use of standardised material characteristics conventionally used in Engineering Geology applications, will prove useful as we develop increasingly sophisticated strategies such as cyclic soft stimulation to access resources using less energy, whilst reducing environmental risk and producing less waste.</p

Preconception care: advancing from 'important to do and can be done' to 'is being done and is making a difference'

There is a growing evidence base for preconception care--the provision of biomedical, behavioral and social interventions to women and couples before conception occurs. Firstly, there is evidence that health problems, problem behaviours and individual and environmental risks contribute to poor maternal and child health outcomes. Secondly, there are biomedical, behavioural and social interventions that when delivered beforeconception occurs, effectively address many of these health problems, problem behaviours and risk factors.And thirdly, there is emerging experience of how to deliver these interventions in low and middle income countries (LMIC).The preconception care interventions delivered and whom they are delivered to, will need to be tailored to local realities. The package of preconception care interventions delivered in a particular setting will depend on the local epidemiology, the interventions already being delivered, and the resources in place to deliver additionalinterventions. Although a range of population groups could benefit from preconception care, prioritization based on need and feasibility will be needed.There are both potential benefits and risks associated with preconception care. Preconception care could result in large health and social benefits in LMIC. It could also be misused to limit the autonomy of women and reinforce the notion that the focus of all efforts to improve the health of girls and women should be at improving maternal and child health outcomes rather than at improving the health of girls and women as individuals in their own right.There are challenges in delivering preconception care. While the potential benefits of preconception care programmes could be substantial, extending the traditional Maternal and Child Health package will be both a logistic and financial challenge.We need to help countries set and achieve pragmatic and meaningful short term goals. While our longterm goal for preconception care should be for a full package of health and social interventions to be delivered to all women and couples of reproductive age everywhere, our short-term goals must be pragmatic. This is because countries that need preconception care most are the ones least likely to be able to afford them and deliver them.If we want these countries to take on the additional challenge of providing preconception care while they struggle to increase the coverage of prenatal care, skilled care at birth etc., we must help them identify and deliver a small number of effective interventions based on epidemiology and feasibility.Elizabeth Mason, Venkatraman Chandra-Mouli, Valentina Baltag, Charlotte Christiansen, Zohra S Lassi, Zulfiqar A Bhutt

iPrevent

Curso de Especial InterésLa siguiente propuesta, contiene la información necesaria para poder asesorar y brindar una mejor atención a los procesos que son inherentes a la sexualidad del ser humano. El diseño de la creación de una aplicación llamada iPrevent, usada en aparatos tecnológicos como los móviles con sistema Android y Apple. Esta aplicación está encaminada a presentar y a exponer los distintos métodos anticonceptivos que se encuentran en el mercado, así mismo brindar un marco de conocimiento de cada uno, para facilitar la toma de decisiones de los adolescentes; de esta manera teniendo una correlación con la salud pública y mitigar los embarazos no deseados y posibles interrupciones voluntarias del embarazo (IVE) y uso de Métodos Anticonceptivos de emergencia en esta población.101 p.1. Resumen 2. Justificación 3. Marco teórico 4. Objetivos 5. Metodología 6. Estudio de mercadeo 7. Resultados 8. Discusión 9. Conclusiones y recomendaciones 10. Referencias 11. ApéndicesPregradoPsicólog

Genomic sequencing in clinical trials

Human genome sequencing is the process by which the exact order of nucleic acid base pairs in the 24 human chromosomes is determined. Since the completion of the Human Genome Project in 2003, genomic sequencing is rapidly becoming a major part of our translational research efforts to understand and improve human health and disease. This article reviews the current and future directions of clinical research with respect to genomic sequencing, a technology that is just beginning to find its way into clinical trials both nationally and worldwide. We highlight the currently available types of genomic sequencing platforms, outline the advantages and disadvantages of each, and compare first- and next-generation techniques with respect to capabilities, quality, and cost. We describe the current geographical distributions and types of disease conditions in which these technologies are used, and how next-generation sequencing is strategically being incorporated into new and existing studies. Lastly, recent major breakthroughs and the ongoing challenges of using genomic sequencing in clinical research are discussed

Variants in the GPR146 Gene Are Associated With a Favorable Cardiometabolic Risk Profile

BACKGROUND: In mice, GPR146 (G-protein-coupled receptor 146) deficiency reduces plasma lipids and protects against atherosclerosis. Whether these findings translate to humans is unknown. METHODS: Common and rare genetic variants in the GPR146 gene locus were used as research instruments in the UK-Biobank. The Lifelines, and The Copenhagen-City Heart Study, and a cohort of individuals with familial hypobetalipoproteinemia were used to find and study rare GPR146 variants. RESULTS: In the UK-Biobank, carriers of the common rs2362529-C allele present with lower low-density lipoprotein cholesterol, apo (apolipoprotein) B, high-density lipoprotein cholesterol, apoAI, CRP (C-reactive protein), and plasma liver enzymes compared with noncarriers. Carriers of the common rs1997243-G allele, associated with higher GPR146 expression, present with the exact opposite phenotype. The associations with plasma lipids of the above alleles are allele dose-dependent. Heterozygote carriers of a rare coding variant (p.Pro62Leu; n=2615), predicted to be damaging, show a stronger reductions in the above parameters compared with carriers of the common rs2362529-C allele. The p.Pro62Leu variant is furthermore shown to segregate with low low-density lipoprotein cholesterol in a family with familial hypobetalipoproteinemia. Compared with controls, carriers of the common rs2362529-C allele show a marginally reduced risk of coronary artery disease (P=0.03) concomitant with a small effect size on low-density lipoprotein cholesterol (average decrease of 2.24 mg/dL in homozygotes) of this variant. Finally, mendelian randomization analyses suggest a causal relationship between GPR146 gene expression and plasma lipid and liver enzyme levels. CONCLUSIONS: This study shows that carriers of new genetic GPR146 variants have a beneficial cardiometabolic risk profile, but it remains to be shown whether genetic or pharmaceutical inhibition of GPR146 protects against atherosclerosis in humans

Alternative Strategies to Reduce Maternal Mortality in India: A Cost-Effectiveness Analysis

A cost-effectiveness study by Sue Goldie and colleagues finds that better family planning, provision of safe abortion, and improved intrapartum and emergency obstetrical care could reduce maternal mortality in India by 75% in 5 years